Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022.
Front Immunol. 2022.
PMID: 36105814
Free PMC article.
Clinical Trial.
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.
Valim V, Machado KLLL, Miyamoto ST, Pinto AD, Rocha PCM, Serrano EV, Dinis VG, Gouvêa SA, Dias JGF, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, da Costa-Rocha IA, de Lima SMB, Miranda EH, Trindade GF, Maia MLS, Gavi MBRO, da Silva LB, Duque RH, Gianordoli APE, Casagrande TZ, Oliveira KG, Moura BCDM, Nicole-Batista F, Rodrigues LC, Clemente TB, Magalhães ES, Bissoli MF, Gouvea MDPG, Pinto-Neto LFDS, Costa CZ, Giovelli RA, Brandão LR, Polito ETL, Koehlert IO, Borjaille BP, Pereira DB, Dias LH, Merlo DL, Genelhu LFF, Pretti FZ, Giacomin MDS, Burian APN, Fantinato FFST, Pileggi GS, da Mota LMH, Martins-Filho OA.
Valim V, et al. Among authors: gouvea mdpg.
Front Immunol. 2020 Jul 17;11:1382. doi: 10.3389/fimmu.2020.01382. eCollection 2020.
Front Immunol. 2020.
PMID: 32765496
Free PMC article.
Item in Clipboard
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.
da Costa-Rocha IA, Machado KLLL, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, de Lima SMB, Miranda EH, Trindade GF, Casagrande TZ, Miyamoto ST, Deotti SC, Barbosa RVR, Rocha PCM, Serrano EV, Dinis VG, Gouvêa SA, Gavi MBRO, da Silva LB, Duque RH, Gianordoli APE, Bissoli MF, Gouvea MDPG, Pinto-Neto LFDS, Burian APN, Fantinato FFST, Pileggi GS, da Mota LMH, Valim V, Martins-Filho OA.
da Costa-Rocha IA, et al. Among authors: gouvea mdpg.
Sci Rep. 2021 May 17;11(1):10431. doi: 10.1038/s41598-021-89770-8.
Sci Rep. 2021.
PMID: 34001945
Free PMC article.
Item in Clipboard
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
Casagrande TZ, Costa-Rocha IAD, Gavi MBRO, Miyamoto ST, Martins PC, Serrano ÉV, Dinis VG, Machado KLLL, Gouvea SA, Caser LC, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, Bissoli MF, Gouvea MDPG, Lima SMB, Miranda EH, Trindade GF, Lyra DGP, Burian APN, Neto LFDSP, da Mota LMH, Martins-Filho OA, Valim V.
Casagrande TZ, et al. Among authors: gouvea mdpg.
Vaccine. 2022 Jul 30;40(32):4580-4593. doi: 10.1016/j.vaccine.2022.05.071. Epub 2022 Jun 18.
Vaccine. 2022.
PMID: 35728990
Item in Clipboard
Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence.
Gouvea MDPG, Moulaz IR, Gouveia TM, Lança KEM, Lacerda BSP, Thompson BP, Polese J, Lima MD, Ribeiro-Rodrigues R, Mill JG, Valim V.
Gouvea MDPG, et al.
Rev Soc Bras Med Trop. 2022 Oct 24;55:e01062022. doi: 10.1590/0037-8682-0106-2022. eCollection 2022.
Rev Soc Bras Med Trop. 2022.
PMID: 36287469
Free PMC article.
Item in Clipboard
Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases.
Galvão-Lima LJ, de Medeiros Júnior NF, Jesus GS, Morais AHF, Caldeira-Silva GJP, Queiroz Dos Santos JP, Rocha M, Marques Dos Santos M, Freire PA, Silva RD, Gouvea MDPG, Neto LFP, Domingues CMAS, Teixeira-Carvalho A, Martins-Filho OA, Valim V, Valentim RAM.
Galvão-Lima LJ, et al. Among authors: gouvea mdpg.
IJID Reg. 2023 Sep 30;9:88-94. doi: 10.1016/j.ijregi.2023.09.007. eCollection 2023 Dec.
IJID Reg. 2023.
PMID: 37953882
Free PMC article.
Item in Clipboard
Cite
Cite